NCT03462199 - Evaluating Efficacy of Investigational Products on Spontaneous Bowel Movements in Healthy People With ≤ 3 Complete Weekly Spontaneous Bowel Movements | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

March 23, 2018

Primary Completion Date

February 1, 2020

Study Completion Date

February 3, 2020

Conditions

Functional ConstipationHealthy

Interventions

DIETARY_SUPPLEMENT

Actazin (green kiwi powder) High Dose

Participants will consume 4 capsules (600 mg green kiwi powder) daily for 28-days

DIETARY_SUPPLEMENT

Actazin (green kiwi powder) Low Dose

Participants will consume 4 capsules (150 mg green kiwi powder) daily for 28-days

DIETARY_SUPPLEMENT

Control Formula (Actazin green kiwi powder + PreticX prebiotic)

Participants will consume 4 capsules (150 mg green kiwi powder + 250 mg PreticX prebiotic) daily for 28-days

DIETARY_SUPPLEMENT

Livaux (gold kiwi powder) High Dose

Participants will consume 4 capsules (600 mg gold kiwi powder) daily for 28-days

DIETARY_SUPPLEMENT

Livaux (gold kiwi powder) Low Dose

Participants will consume 4 capsules (150 mg gold kiwi powder) daily for 28-days

DIETARY_SUPPLEMENT

Placebo (microcrystalline cellulose)

Participants will consume 4 capsules containing no active ingredients daily for 28-days

Trial Locations (1)

KGK Clinical Trial Centers, London